|
|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Type 2 diabetes w prolif diabetic rtnop w/o macular edema
ICD-10 (CM) Code and Descriptor
|
E11.3592 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye
|
E113592 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 35.91%
|
30.81%
|
11.35%
|
6.76%
|
3.78%
|
2.97%
|
1.71%
|
1.82%
|
1.12%
|
1.05%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E11.3592*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
490
|
492
|
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
478
|
478
|
|
67028
|
INJECTION EYE DRUG |
308
|
308
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
252
|
1,608
|
|
67040
|
LASER TREATMENT OF RETINA |
242
|
242
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
236
|
4,349
|
|
C9257
|
BEVACIZUMAB INJECTION |
235
|
1,426
|
|
J3010
|
FENTANYL CITRATE INJECTION |
219
|
269
|
|
82962
|
GLUCOSE BLOOD TEST |
212
|
255
|
|
67228
|
TREATMENT X10SV RETINOPATHY |
207
|
207
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
189
|
409
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
183
|
1,108
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
180
|
308
|
|
97530
|
THERAPEUTIC ACTIVITIES |
177
|
336
|
|
J0171
|
ADRENALIN EPINEPHRINE INJECT |
174
|
1,255
|
|
97110
|
THERAPEUTIC EXERCISES |
169
|
399
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
157
|
157
|
|
J2405
|
ONDANSETRON HCL INJECTION |
156
|
641
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
154
|
154
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
138
|
821
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E11.3592 related to the following DRG Codes:
008
010
019
124-125
|
